C0596290||Proliferation
C2699153||Invasion
C1254351||Drug
C0162638||Apoptosis
C0023448||Lymphoblastic Leukemia
C0015352||extracellular
C0027651||tumors
C0178874||tumor progression
C0040300||tissues
C2603343||study
C0015352||extracellular
C0596290||proliferation
C2699153||invasion
C1254351||drug
C0162638||apoptosis
C0883208||acute lymphoblastic cells
C0883208||cells
C0596290||Cell proliferation
C2986858||MTT assay
C2699153||cell invasion
C0022885||invasion assay
C1880945||gene expression analysis
C0165519||MMP-9
C1254351||Drug
C0162638||apoptosis
C0013089||doxorubicin
C0059249||annexin V
C0033470||PI
C0487602||staining
C1880945||gene expression analysis
C0219474||BAX pro-apoptotic protein
C0007595||growth
C2699153||invasion
C0023418||leukemic
C0007634||cells
C0007634||cells
C0162638||apoptosis
C0013089||doxorubicin
C0596290||proliferation
C2699153||invasion
C1254351||drug
C0162638||apoptosis
C0023449||acute lymphoblastic leukemia
C0015352||Extracellular
C0023418||leukemic
C0007634||cells
C0015349||extracellular liquid
C0087111||therapeutic strategy
C0023418||leukemia
C0023449||acute lymphoblastic leukemia